Metabonomics Combined with UPLC-MS Chemical Profile for Discovery of Antidepressant Ingredients of a Traditional Chinese Medicines Formula, Chaihu-Shu-Gan-San
Figure 3
(a) Urinary metabolic pathways of CUMS-induced depression with CSGS or QZ treatment. Metabolites in red font: the potential biomarkers on which CSGS had regulations but QZ did not; metabolites in blue font: the potential biomarkers on which QZ had regulations but CSGS did not. (b) The levels of 12 potential biomarkers for differentiating CSGS and QZ treated. (* versus CUMS group, ** versus CUMS group).
(a)
(b)
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.
